50419-0393 VITRAKVI - CanMED: NDC

Product NDC:

50419-0393

Brand Name:

VITRAKVI

Generic Name:

LAROTRECTINIB

Dosage Form Name:

SOLUTION, CONCENTRATE

Administration Route:

OROPHARYNGEAL

Substances:

Name: LAROTRECTINIB

Strength: 20.0

Unit: mg/mL

Packages:

Code: 50419-0393-03

Description: 2 BOTTLE in 1 CARTON (50419-393-03) / 50 mL in 1 BOTTLE (50419-393-02)

Effective Date: Dec. 6, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

TRK

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox